ARTICLE | Clinical News
TP-434: Phase I data
September 20, 2010 7:00 AM UTC
In a pair of placebo-controlled Phase I trials evaluating single (n=56) and multiple (n=32) ascending doses of IV TP-434 in healthy volunteers, the compound displayed linear and dose-proportional plas...